Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Retained Earnings (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Retained Earnings for 16 consecutive years, with -$68.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings fell 9.5% to -$68.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$68.7 million, a 9.5% decrease, with the full-year FY2024 number at -$64.6 million, down 9.3% from a year prior.
  • Retained Earnings was -$68.7 million for Q3 2025 at Creative Medical Technology Holdings, down from -$67.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$34.1 million in Q1 2021 to a low of -$68.7 million in Q3 2025.
  • A 5-year average of -$54.0 million and a median of -$56.0 million in 2023 define the central range for Retained Earnings.
  • Biggest YoY gain for Retained Earnings was 29.44% in 2021; the steepest drop was 66.75% in 2021.
  • Creative Medical Technology Holdings' Retained Earnings stood at -$43.7 million in 2021, then decreased by 23.23% to -$53.8 million in 2022, then dropped by 9.82% to -$59.1 million in 2023, then decreased by 9.3% to -$64.6 million in 2024, then fell by 6.36% to -$68.7 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Retained Earnings are -$68.7 million (Q3 2025), -$67.5 million (Q2 2025), and -$66.2 million (Q1 2025).